SCHEMBL7012471

SCHEMBL7012471

Cc1nc2[nH]c(=O)n(C[C@@H](S)CS)c(=O)c2nc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 7/20 0.36
MEN1 O00255 7/20 0.36
KMT2A Q03164 7/20 0.36
RGS12 O14924 6/20 0.36
KDM4E B2RXH2 5/20 0.36
MAPT P10636 5/20 0.36
POLB P06746 4/20 0.36
ALDH1A1 P00352 3/20 0.36
KEAP1 Q14145 2/20 0.35
NFE2L2 Q16236 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 2/20 0.35
PKM P14618 1/20 0.35
MCOLN3 Q8TDD5 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
BLM P54132 1/20 0.34
CACNA1B Q00975 1/20 0.34
APBA1 Q02410 1/20 0.34
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7012468 1.00 USP2 (0.36) USP2MEN1KMT2ARGS12KDM4E
SCHEMBL7258493 0.86 USP2 (0.38) USP2MEN1KMT2ARGS12KDM4E
SCHEMBL7105873 0.86 USP2 (0.38) USP2MEN1KMT2ARGS12KDM4E
SCHEMBL7014592 0.79 FEN1 (0.35) USP2MEN1KMT2ARGS12KDM4E
SCHEMBL7014590 0.79 FEN1 (0.35) USP2MEN1KMT2ARGS12KDM4E
SCHEMBL7020404 0.76 KDM4E (0.45) KDM4E
SCHEMBL7020408 0.76 KDM4E (0.45) KDM4E
SCHEMBL7017348 0.74 USP2 (0.35) USP2MEN1KMT2ARGS12KDM4E
SCHEMBL7017351 0.74 USP2 (0.35) USP2MEN1KMT2ARGS12KDM4E
SCHEMBL7022158 0.72 USP2 (0.38) USP2MEN1KMT2ARGS12KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1357114-A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP) IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) 2003-10-29 EP disclosed